StudyYuichiro Yamada et al <br/><br/>
Efficacy and Safety of GPR119 Agonist DS-8500a in Japanese Patients with Type 2 Diabetes: a Randomized, Double-Blind, Placebo-Controlled, 12-Week 

<br/><br/><label>Subjects--Topical Terms: </label><br/>Computer science, information & general works